Deintensified Chemoradiotherapy for Pretreatment Epstein-Barr Virus DNA-Selected Low-Risk Locoregionally Advanced Nasopharyngeal Carcinoma: A Phase II Randomized Noninferiority Trial.

Xiao-Yun LiDong-Hua LuoLing GuoHao-Yuan MoRui SunShan-Shan GuoLi-Ting LiuZhen-Chong YangJin-Hao YangFang QiuXue-Song SunPan WangQing LiuJi-Bin LiQing-Nan TangChao LinQi YangSai-Lan LiuYu-Jing LiangGuo-Dong JiaDong-Xiang WenChun-Yan GuoJin-Jie YanChong ZhaoQiu-Yan ChenLin-Quan Tang Hai-Qiang Mai

Published in: Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2022)

DDP could be an alternative treatment option for patients with low-risk LA-NPC.

Keyphrases

phase ii
epstein barr virus
open label
clinical trial
phase iii
placebo controlled
double blind
diffuse large b cell lymphoma
study protocol
rectal cancer
single molecule
circulating tumor
randomized controlled trial
radiation therapy
smoking cessation